July 29, 2019
UCLA surgeons perform California’s first deep brain stimulation for epilepsy following FDA approval
By uclahealth 
The Food and Drug Administration (FDA) has approved the use of a procedure that is highly beneficial for people with movement disorders such as Parkinson’s disease to treat some patients with severe epilepsy. The procedure, deep brain stimulation (DBS), involves implantation of a “brain pacemaker” to send electrical impulses to targeted areas of the brain […]
Tags: DBS, deep brain stimulation, Department of Neurosurgery, Dr. Aria Fallah, Dr. Ausaf Bari, FDA, Food and Drug Administration, neurosurgeon, Parkinson’s disease, severe epilepsy, UCLA Seizure Disorder Center
November 16, 2016
A new hope: Innovative options for patients with intractable epilepsy
By uclahealth
Patients with intractable epilepsy have seizures that are difficult to control with medication. These uncontrolled seizures are a serious health condition that be potentially life-threatening. But there is hope for patients with intractable epilepsy. The UCLA Epilepsy Program is a unique program that offers multiple approaches for treating patients, from traditional surgery to innovative nonsurgical […]
Tags: brain tissue, clinical trials, Dr. Dawn Eliashiv, Dr. Jerome Engel Jr, Dr. John Stern, electrical abnormality, epilepsy, experimental drug tria, intractable epilepsy, laser thermal ablation, medication, minimally invasive
